Condition: Acute Kidney Injury · Renal Replacement Therapy · Hypotension · Sponsor: Ottawa Hospital Research Institute
Study objectives: To determine whether, in critically ill patients with Acute Kidney Injury requiring renal replacement therapy (AKI-RRT), randomization to receive intravenous hyperoncotic albumin 20-25% (100 mL X two doses) compared to control/placebo normal saline boluses (100 mL X two doses) given during RRT sessions, leads to: 1. An increase in organ support-free days (primary outcome) at 28 days following randomization; and 2. An increase in RRT-free days (principal secondary outcome) at 28 days following randomization.
This description comes directly from the study's public registry record.
Edward G Clark, MD MSc FRCPC · 613-737-8899 · edclark@toh.ca
Irene Watpool, RN BScN · 613-737-8724 · iwatpool@ohri.ca
Always discuss trial participation with your own doctor first.
| The Governors of the University of Calgary | Calgary, Alberta, Canada | Not Yet Recruiting |
| University of Manitoba - Health Sciences Centre | Winnipeg, Manitoba, Canada | Not Yet Recruiting |
| Nova Scotia Health Authority | Halifax, Nova Scotia, Canada | Not Yet Recruiting |
| Hamilton Health Sciences Corporation | Hamilton, Ontario, Canada | Recruiting |
| Kingston General Hospital | Kingston, Ontario, Canada | Recruiting |
| Sunnybrook Health Sciences Centre | North York, Ontario, Canada | Recruiting |
| The Ottawa Hospital | Ottawa, Ontario, Canada | Recruiting |
| University of Ottawa Heart Institute | Ottawa, Ontario, Canada | Recruiting |
| Scarborough Health Network | Scarborough Village, Ontario, Canada | Not Yet Recruiting |
| Niagara Health System | St. Catharines, Ontario, Canada | Recruiting |
| St. Michael's Hospital | Toronto, Ontario, Canada | Not Yet Recruiting |
| Sinai Health System | Toronto, Ontario, Canada | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04705896